<SEC-DOCUMENT>0001493152-26-031917.txt : 20260702
<SEC-HEADER>0001493152-26-031917.hdr.sgml : 20260702
<ACCEPTANCE-DATETIME>20260702163031
ACCESSION NUMBER:		0001493152-26-031917
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20260629
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260702
DATE AS OF CHANGE:		20260702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANGOCEUTICALS, INC.
		CENTRAL INDEX KEY:			0001938046
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				873841292
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41615
		FILM NUMBER:		261151875

	BUSINESS ADDRESS:	
		STREET 1:		15110 DALLAS PKWY, SUITE 600
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75248
		BUSINESS PHONE:		(833) 626-4679

	MAIL ADDRESS:	
		STREET 1:		15110 DALLAS PKWY, SUITE 600
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75248
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:us-roles="http://fasb.org/us-roles/2026" xmlns:country="http://xbrl.sec.gov/country/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:MGRX="http://mangoceuticals.com/20260629">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02F_US%2DGAAP%2D2026 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_MGRX_mangoceuticals.com_20260629 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20260629_20260629 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001938046 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000004" name="dei:EntityCentralIndexKey">0001938046</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="mgrx-20260629.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-06-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001938046</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-06-29</xbrli:startDate>
        <xbrli:endDate>2026-06-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90F_edei--DocumentType_c20260629__20260629_zEtdNniZFzy"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of Earliest Event Reported): <b><span id="xdx_905_edei--DocumentPeriodEndDate_c20260629__20260629_zRTSEQooli0h"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 29, 2026</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_900_edei--EntityRegistrantName_c20260629__20260629_z5CQ2Ddw79r2"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000011" name="dei:EntityRegistrantName">MANGOCEUTICALS,
INC.</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20260629__20260629_zb8oJcb36IOa"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20260629__20260629_zLixj08RRmP3"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000013" name="dei:EntityFileNumber">001-41615</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20260629__20260629_zWiv6CkMQeF3"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000014" name="dei:EntityTaxIdentificationNumber">87-3841292</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20260629__20260629_zknQStNtfh9i"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000015" name="dei:EntityAddressAddressLine1">17130
    N. Dallas Parkway</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20260629__20260629_zECjfStJmDjl"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 240</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20260629__20260629_zxCt27rOoFCb"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000017" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>,
    <span id="xdx_90E_edei--EntityAddressStateOrProvince_c20260629__20260629_ztK4KOoX7Skd"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20260629__20260629_zrjRuUcFvaM4"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000019" name="dei:EntityAddressPostalZipCode">75248</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address of principal
    executive offices)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant&#8217;s
telephone number, including area code: <span id="xdx_902_edei--CityAreaCode_c20260629__20260629_zNJM93M37iD1"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000020" name="dei:CityAreaCode">(214)</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20260629__20260629_zCHgapd5CMM9"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000021" name="dei:LocalPhoneNumber">242-9619</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--WrittenCommunications_c20260629__20260629_zUXyAvegiZof"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20260629__20260629_zhGLRHa3gIY6"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20260629__20260629_zhLoYjkRlJLf"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20260629__20260629_z3drdDgRHeqf"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20260629__20260629_zYKW5n0v8VV7"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000026" name="dei:Security12bTitle">Common Stock, $0.0001 Par
    Value Per Share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--TradingSymbol_c20260629__20260629_zrqGWGt85fma"><ix:nonNumeric contextRef="AsOf2026-06-29" id="Fact000027" name="dei:TradingSymbol">MGRX</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--SecurityExchangeName_c20260629__20260629_z9XAtQAFdoE5"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
Nasdaq Stock Market LLC</ix:nonNumeric></span></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Nasdaq
    Capital Market)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20260629__20260629_z2EuVsbBpkEb"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_906_edei--EntityExTransitionPeriod_c20260629__20260629_zbeZ4qcbq7ni"><ix:nonNumeric contextRef="AsOf2026-06-29" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Private
Placement Subscriptions</span></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 29, 2026, Mangoceuticals, Inc. (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;, &#8220;<span style="text-decoration: underline">we</span>&#8221; and &#8220;<span style="text-decoration: underline">us</span>&#8221;) entered into
a Subscription Agreement with an accredited investor (the &#8220;<span style="text-decoration: underline">Investor</span>&#8221;), pursuant to which the Investor purchased 850,000
shares of restricted common stock from the Company, for $0.32 per share, or a total of $272,000. The Subscription Agreement included
customary representations and warranties of the Investor and the Company and includes piggyback registration rights for a period of one
year following the dates of the subscription.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
description of the Subscription Agreement above is not complete and is qualified in its entirety by the full text of the form of Subscription
Agreement, a copy of which is attached hereto as <span style="text-decoration: underline">Exhibit 10.1</span>, and which is incorporated by reference into this <span style="text-decoration: underline">Item 1.01</span>
in its entirety by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in <span style="text-decoration: underline">Item 1.01</span> above is incorporated by reference into this Item 3.02 in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company claims an exemption from registration for the issuance of the shares to the Investor (as discussed in <span style="text-decoration: underline">Item 1.01</span>, above),
pursuant to Section 4(a)(2) and/or Rule 506 of Regulation D of the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;),
since the offer and sale of such shares did not involve a public offering and the recipient was an &#8220;<span style="text-decoration: underline">accredited investor</span>&#8221;
and had access to similar information as would be included in a registration statement under the Securities Act. The securities were
offered without any general solicitation by us or our representatives. No underwriters or agents were involved in the foregoing offers
and sales and we paid no underwriting discounts or commissions. The securities are subject to transfer restrictions, and the securities
contain an appropriate legend stating that such securities have not been registered under the Securities Act and may not be offered or
sold absent registration or pursuant to an exemption therefrom. The securities were not registered under the Securities Act and such
securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities
Act and any applicable state securities laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Common Stock Subscription Agreement</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (embedded within the Inline XBRL document and included in Exhibit 101).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Filed herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">MANGOCEUTICALS, INC.</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: July 2, 2026</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>By:</i></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jacob D. Cohen</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob D. Cohen</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdpNHbJLh4o4ZQwRb4vLpLg1I60/eyTf0rohhkBIzvlyhBiJDa11jQznZZHBEZu2Vg6hwAoZzQW9I93uEvCzwKu2jpVx/foDU/IMeiYez5W/986HtlgmIOPJVE6iGOQimcWQ70Xw1VMylS7ROK1qUKaEnKlljU5xN3w4qhcZaro+6YRsNZkEwrEc5DdEMozgQA/1JL5ZyLJUBKO+ArFhurfetXo5NF8SVjU2Ps4O9L+DD9IpSmc= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUBSCRIPTION
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANGOCEUTICALS,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>A.
</I><U>Subscription</U>. This Agreement has been executed by __________________________, a/an <I>(<U>Individual/Corporation/LLC/Trust/Partnership</U>)</I>,
residing and/or having a principal place of business in <I>(<U>Country/State and City</U>)</I> (&ldquo;<B><U>Purchaser</U></B>&rdquo;,
or &ldquo;<B><U>Subscriber&rdquo;)</U></B> in connection with the subscription to purchase _________ restricted shares of common stock,
$0.0001 par value per share (&ldquo;<B><U>Common Stock</U></B>&rdquo;) of the Company (the &ldquo;<B><U>Shares</U></B>&rdquo; or the
&ldquo;<B><U>Securities</U></B>&rdquo;), from Mangoceuticals, Inc., a Texas corporation (the &ldquo;<B><U>Company</U></B>&rdquo;). This
Subscription Agreement is referred to herein as the &ldquo;<B><U>Agreement</U></B>&rdquo; or the &ldquo;<B><U>Subscription</U></B>&rdquo;.
The Company is selling Securities to multiple investors, as part of a &ldquo;<B><U>best efforts, no minimum</U></B>&rdquo; offering,
defined herein as the &ldquo;<B><U>Offering</U></B>&rdquo;. The Offering is made in reliance upon an exemption from registration under
the federal securities laws provided by. Section 4(a)(2) and/or Rule 506(b) of Regulation D of the Securities Act of 1933, as amended.
The purchase price of each Share is $0.32 (the &ldquo;<B><U>Purchase Price</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reserves the right to reject orders for the purchase of Securities in whole or in part, and if a subscription is rejected the
subscriber&rsquo;s funds will be returned without interest the next business day after rejection. There is no amount required for an
initial closing, and all proceeds will be available for immediate use by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the context in which words are used in this Subscription Agreement (&ldquo;<B><U>Agreement</U></B>&rdquo;) indicates that such is the
intent, singular words shall include the plural, and vice versa, and masculine words shall include the feminine and neuter genders, and
vice versa. Any reference to a person shall include an individual, trust, estate, or any incorporated or unincorporated organization,
including general or limited partnerships, limited liability companies, corporations, joint ventures and cooperatives, and all heirs,
executors, administrators, legal representatives, successors and assigns of such person where permitted or required by the context. Captions
are inserted for convenience only, are not a part of this Agreement, and shall not be used in the interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
<U>Acceptance of Subscription</U>. It is understood and agreed that the Company shall have the right to accept or reject this subscription
(the &ldquo;<B><U>Subscription</U></B>&rdquo;), in whole or in part, and that the same shall be deemed to be accepted by the Company
only when it is signed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
<U>Representations and Warranties of Subscriber</U>. Subscriber hereby represents and warrants to the Company as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
Subscriber has such knowledge and experience in financial and business matters that Subscriber is capable of evaluating the merits and
risks of an investment in the Company and the suitability of the Securities as an investment for Subscriber;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)
Subscriber is an &ldquo;<B><U>Accredited Investor</U></B>&rdquo; as such term is defined in Rule 501 of the Securities Act of 1933, as
amended (the &ldquo;<B><U>Securities Act</U></B>&rdquo; or the &ldquo;<B><U>Act</U></B>&rdquo;), and has completed the Investor Application
(Qualification Questionnaire) attached hereto as <U>Exhibit 1</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii)
The Subscriber is acquiring the Securities for its own account for long-term investment and not with a view toward resale, fractionalization
or division, or distribution thereof, and it does not presently have any reason to anticipate any change in his, her or its circumstances,
financial or otherwise, or particular occasion or event which would necessitate or require his, her or its sale or distribution of the
Securities. No one other than the Subscriber has any beneficial interest in said securities. No person has made to the Subscriber any
written or oral representations: (x) that any person will resell or repurchase any of the Securities; (y) that any person will refund
the purchase price of any of the Securities, or (z) as to the future price or value of any of the Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv)
Subscriber has received no representations or warranties from the Company, or its affiliates, employees or agents regarding the Securities
or suitability of an investment in the Securities or the Company other than those set forth herein and attached hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v)
Subscriber is able to bear the economic risk of the investment in the Securities and Subscriber has sufficient net worth to sustain a
loss of Subscriber&rsquo;s entire investment in the Company without economic hardship if such a loss should occur;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi)
Subscriber has had an opportunity to inspect relevant documents relating to the organization and operations of the Company. Subscriber
acknowledges that all documents, records and books pertaining to this investment which Subscriber has requested have been made available
for inspection by Subscriber and Subscriber&rsquo;s attorney, accountant or other adviser(s);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii)
Subscriber has had an opportunity to ask questions of and receive satisfactory answers from the Company, or any person or persons acting
on behalf of the Company, concerning the terms and conditions of this investment and the Offering and the Securities, and all such questions
have been answered to the full satisfaction of Subscriber. The Company has not supplied Subscriber any information for investment purposes
other than as contained in this Agreement and the attachments hereto, and Subscriber is relying on its own investigation and evaluation
of the Company and the Securities in making an investment hereunder and not on any other information whatsoever, including, but not limited
to, any presentations or other materials, other than this Agreement and the attachments, provided to the Subscriber by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">viii)
Subscriber is able to bear the economic risk of the investment in the Securities and Subscriber has sufficient net worth to sustain a
loss of Subscriber&rsquo;s entire investment in the Company without economic hardship if such a loss should occur;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ix)
The Subscriber recognizes that the investment herein is a speculative venture and that the total amount of funds tendered to purchase
Securities is placed at the risk of the business and may be completely lost. The purchase of Securities as an investment involves special
risks;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x)
The Subscriber: (i) if a natural person, represents that the Subscriber has reached the age of 21 and has full authority, legal capacity
and competence to enter into, execute and deliver this Agreement and all other related agreements or certificates and to take all actions
required pursuant hereto and thereto and to carry out the provisions hereof and thereof, or (ii) if a corporation, partnership, or limited
liability company or partnership, or association, joint stock company, trust, unincorporated organization or other entity, represents
that such entity was not formed for the specific purpose of acquiring the Securities and such entity is duly organized, validly existing
and in good standing under the laws of the state of its organization. Subscriber is a bona fide resident and domiciliary of the state
set forth in the <U>Investor Application</U> (the &ldquo;<B><U>Qualification Questionnaire</U></B>&rdquo;) and has no present intention
to become a resident of any other state or jurisdiction. Any individual executing this Agreement on behalf of an entity has authority
to act on behalf of such entity and has been duly and properly authorized to sign this Agreement on behalf of such entity, provided further
that such entity has validly authorized and approved such entity&rsquo;s entry into this Agreement and the transactions contemplated
herein. The purchase of Securities as an investment involves special risks;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xi)
The Subscriber is a bona fide resident or operates its principal place of business as set forth in this Subscription Agreement and Qualification
Questionnaire, which Qualification Questionnaire Subscriber has completed completely and honestly;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xii)
Subscriber acknowledges and is aware of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
There are substantial restrictions on the transferability of the Securities; the Securities will not be, and investors in the Company
have no right to require that the Securities be registered under the Securities Act; there may not be any public market for the Securities;
Subscriber may not be able to use the provisions of Rule 144 of the Securities Act with respect to the resale of the Securities; and
accordingly, Subscriber may have to hold the Securities indefinitely and it may not be possible for Subscriber to liquidate Subscriber&rsquo;s
investment in the Company. Subscriber agrees that the Securities shall not be sold, transferred, pledged or hypothecated unless such
sale is exempt from registration under the Securities Act. Subscriber also acknowledges that Subscriber shall be responsible for compliance
with all conditions on transfer imposed by any blue sky or securities law administrator and for any expenses incurred by the Company
for legal or accounting services in connection with reviewing a proposed transfer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
No federal or state agency has made any finding or determination as to the fairness of the Offering of the Securities for investment
or any recommendation or endorsement of the Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
The Securities have not been approved or registered under any Blue Sky law or with any State Securities Division, in reliance on exemptions
from registration therefrom, and as such, there may be restrictions on the sale or transfer of such Securities under State law; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
The purchase of Securities under this Subscription Agreement is expressly conditioned upon the exemption from qualification of the offer
and sale of the Securities from applicable Federal, state and provincial securities laws. The Company shall not be required to qualify
this transaction under the securities laws of any jurisdiction and, should qualification be necessary, the Company shall be released
from any and all obligations to maintain its offer, and may rescind any sale contracted, in the jurisdiction; provided, however, that
upon any such rescission, the Company shall promptly return to Subscriber all funds received by the Company from the Subscriber prior
to such rescission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xiii)
The Subscriber has carefully considered and has, to the extent it believes such discussion is necessary, discussed with its professional,
legal, tax and financial advisors, the suitability of an investment in the Securities for its particular tax and financial situation
and that the Subscriber and its advisers, if such advisors were deemed necessary, have determined that the Securities are a suitable
investment for it;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xiv)
The Subscriber has not become aware of this Offering and has not been offered Securities by any form of general solicitation or advertising,
including, but not limited to, advertisements, articles, notices or other communications published in any newspaper, magazine, or other
similar media or television or radio broadcast or any seminar or meeting where, to the Subscriber&rsquo;s knowledge, those individuals
that have attended have been invited by any such or similar means of general solicitation or advertising;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xv)
The Subscriber realizes that the Securities cannot readily be sold and will be restricted securities and therefore the Securities must
not be purchased unless the Subscriber has liquid assets sufficient to assure that such purchase will cause no undue financial difficulties
and the Subscriber can provide for current needs and possible personal contingencies;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xvi)
The Subscriber confirms and represents that it is able (i) to bear the economic risk of its investment, (ii) to hold the Securities for
an indefinite period of time, and (iii) to afford a complete loss of its investment. The Subscriber also represents that it has (x) adequate
means of providing for his, her or its current needs and possible personal contingencies, and (y) has no need for liquidity in this particular
investment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xvii)
The Subscriber understands that the Securities are being offered and sold to it in reliance on specific exemptions from or non-application
of the registration requirements of federal and state securities laws and that the Company is relying upon the truth and accuracy of
the representations, warranties, agreements, acknowledgments and understandings of the Subscriber set forth herein in order to determine
the applicability of such exemptions and the suitability of the Subscriber to acquire the Securities. All information which the Subscriber
has provided to the Company concerning the Subscriber&rsquo;s financial position and knowledge of financial and business matters is correct
and complete as of the date hereof, and if there should be any material change in such information prior to acceptance of this Agreement
by the Company, the Subscriber will immediately provide the Company with such information;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xviii)
The Subscriber has the requisite power and authority to enter into and perform the transactions contemplated by this Agreement and the
purchase of the Securities. The execution, delivery and performance of this Agreement by the Subscriber and the consummation by it of
the transactions contemplated hereby have been duly authorized by all necessary corporate, partnership or other entity action, and no
further consent or authorization of the Subscriber or its Board of Directors, managers, stockholders, members, trustees, holders or partners,
as the case may be, as required. When executed and delivered by the Subscriber, this Agreement shall constitute a valid and binding obligation
of the Subscriber enforceable against the Subscriber in accordance with its terms;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xix)
The Subscriber has not agreed to act with any of the other investors for the purpose of acquiring, holding, voting or disposing of the
Securities purchased hereunder for purposes of Section 13(d) under the Securities Exchange Act of 1934, as amended (the &ldquo;<B><U>Exchange
Act</U></B>&rdquo;), and the Subscriber is acting independently with respect to its investment in the Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xx)
The Subscriber confirms and certifies that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Subscriber is in receipt of and has carefully and thoroughly read and reviewed and understands the Information for Residents of Certain
States, attached as <U>Exhibit 2</U> hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Subscription hereunder is irrevocable by Subscriber, except as required by law, Subscriber is not entitled to cancel, terminate or
revoke this Agreement or any agreements of Subscriber hereunder and that this Subscription Agreement and such other agreements shall
survive the death or disability of Subscriber and shall be binding upon and inure to the benefit of the parties hereto and their respective
heirs, executors, administrators, successors, legal representatives and permitted assigns. If Subscriber is more than one person, the
obligations of Subscriber hereunder shall be joint and several and the agreements, representations, warranties and acknowledgments herein
contained shall be deemed to be made by and be binding upon each such person and his or her heirs, executors, administrators, successors,
legal representatives and permitted assigns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
No federal or state agency has made any findings or determination as to the fairness of the terms of this Offering for investment purposes;
or any recommendations or endorsements of the Securities. The Offering is intended to be exempt from registration under the Securities
Act by virtue of Section 4(a)(2) of the Securities Act and the provisions of Rule 506(b) of Regulation D thereunder, which is in part
dependent upon the truth, completeness and accuracy of the statements made by the Subscriber herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
No person or entity acting on behalf, or under the authority, of Subscriber is or will be entitled to any broker&rsquo;s, finder&rsquo;s
or similar fee or commission in connection with this subscription.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
IN MAKING AN INVESTMENT DECISION, SUBSCRIBER MUST RELY ON ITS OWN EXAMINATION OF THE COMPANY AND THE TERMS OF THE OFFERING, INCLUDING
THE MERITS AND RISKS INVOLVED. THE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY.
ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
THIS SUBSCRIPTION DOES NOT CONSTITUTE AN OFFER OR SOLICITATION IN ANY STATE OR JURISDICTION IN WHICH SUCH AN OFFER OR SOLICITATION IS
NOT PERMITTED UNDER APPLICABLE LAW OR TO ANY FIRM OR INDIVIDUAL THAT DOES NOT POSSESS THE QUALIFICATIONS PRESCRIBED IN THIS SUBSCRIPTION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxi)
The Subscriber confirms and acknowledges that this is a &ldquo;<B><U>best efforts, no minimum</U></B>&rdquo; Offering; that the Company
need not raise any certain level of funding; that regardless of the amount of funding raised in the Offering, the Company will not return
any of the Subscriber&rsquo;s investment herein assuming the Subscription is accepted by the Company; and the Company is not required
to use the funds raised in this Offering for any particular purpose or towards any specific use of proceeds. The Subscriber further confirms
that the Company may undertake additional offerings in the future and/or may issue shares to consultants or employees at offering prices
below that of the Offering, which may cause dilution to the Subscriber;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxii)
The Subscriber expressly represents and warrants to the Company that (a) before executing this Agreement, it has fully informed itself
of the terms, contents, conditions and effects of this Agreement, and the exhibits hereto, the Company and the Shares; (b) the Subscriber
has relied solely and completely upon its own judgment in executing this Agreement; (c) the Subscriber has had the opportunity to seek
and has obtained the advice of its own legal, tax and business advisors before executing this Agreement; and (d) the Subscriber has acted
voluntarily and of its, his or her own free will in executing this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxiii)
The Subscriber acknowledges that it has prior investment experience, including without limitation, investments in non-listed and non-registered
securities, or it has employed the services of an investment advisor, attorney and/or accountant to read all of the documents furnished
or made available by the Company to it and to evaluate the merits and risks of such an investment on its behalf, and that it recognizes
the highly speculative nature of this investment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxiv)
The amounts invested by the Subscriber in the Offering were not and are not directly or indirectly derived from activities that contravene
federal, state or international laws and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive
Orders administered by the Office of Foreign Assets Control (&ldquo;<B><U>OFAC</U></B>&rdquo;) prohibit, among other things, the engagement
in transactions with, and the provision of services to, certain foreign countries, territories, entities and individuals. The lists of
OFAC prohibited countries, territories, persons and entities can be found on the OFAC website at <U>http://www.treas.gov/ofac</U>. In
addition, the programs administered by OFAC (the &ldquo;<B><U>OFAC Programs</U></B>&rdquo;) prohibit dealing with individuals<SUP>1</SUP>
or entities in certain countries regardless of whether such individuals or entities appear on the OFAC lists;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP>
These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject to OFAC
sanctions and embargo programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxv)
The Subscriber understands and acknowledges that (i) the Securities are being offered and sold to Subscriber without registration under
the Securities Act in a private placement that is exempt from the registration provisions under Section 4(a)(2) of the Securities Act,
and Rule 506(b) of Regulation D, and (ii) the availability of such exemption depends in part on, and that the Company will rely upon
the accuracy and truthfulness of, the foregoing representations, and such Subscriber hereby consents to such reliance;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxvi)
The Subscriber certifies, under penalty of perjury, (i) that the social security or Tax Identification Number set forth herein is true,
correct and complete, and (ii) that the Subscriber is not subject to backup withholding under section 3406(a)(1)(c) of the Internal Revenue
Code, as amended (the &ldquo;<B><U>IRC</U></B>&rdquo;) either because the Subscriber has not been notified that the Subscriber is subject
to such backup withholding as a result of a failure to report all interest or dividends, or the Internal Revenue Service has notified
the Subscriber that the Subscriber is no longer subject to backup withholding;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxvii)
To the best of the Subscriber&rsquo;s knowledge, none of: (1) the Subscriber; (2) any person controlling or controlled by the Subscriber;
(3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the Subscriber; or (4) any person for whom
the Subscriber is acting as agent or nominee in connection with this investment is a country, territory, individual or entity named on
an OFAC list, or a person or entity prohibited under the OFAC Programs. The Subscriber understands and acknowledges that the Company
may not accept any amounts from a prospective investor if such prospective investor cannot make the representation set forth in the preceding
paragraph. The Subscriber agrees to promptly notify the Company if the Subscriber becomes aware of any change in the information set
forth in these representations. The Subscriber understands and acknowledges that, by law, the Company may be obligated to &ldquo;<B><U>freeze
the account</U></B>&rdquo; of the Subscriber, either by prohibiting additional subscriptions from the Subscriber, declining any redemption
requests and/or segregating the assets in the account in compliance with governmental regulations, and may also be required to report
such action and to disclose the Subscriber&rsquo;s identity to OFAC. The Subscriber further acknowledges that the Company may, by written
notice to the Subscriber, suspend the redemption rights, if any, of the Subscriber if the Company reasonably deems it necessary to do
so to comply with anti-money laundering regulations applicable to the Company, its Subsidiaries, or any of the Company&rsquo;s other
service providers. These individuals include specially designated nationals, specially designated narcotics traffickers and other parties
subject to OFAC sanctions and embargo programs;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxviii)
To the best of the Subscriber&rsquo;s knowledge, none of: (1) the Subscriber; (2) any person controlling or controlled by the Subscriber;
(3) if the Subscriber is a privately-held entity, any person having a beneficial interest in the Subscriber; or (4) any person for whom
the Subscriber is acting as agent or nominee in connection with this investment is a senior foreign political figure,<SUP>2</SUP> or
any immediate family<SUP>3</SUP> member or close associate<SUP>4</SUP> of a senior foreign political figure, as such terms are defined
in the footnotes below;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP>
A &ldquo;<B><U>senior foreign political figure</U></B>&rdquo; is defined as a senior official in the executive, legislative, administrative,
military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political party,
or a senior executive of a foreign government-owned corporation. In addition, a &ldquo;<B><U>senior foreign political figure</U></B>&rdquo;
includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political figure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3</SUP>
&ldquo;<B><U>Immediate family</U></B>&rdquo; of a senior foreign political figure typically includes the figure&rsquo;s parents, siblings,
spouse, children and in-laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>4</SUP>
A &ldquo;<B><U>close associate</U></B>&rdquo; of a senior foreign political figure is a person who is widely and publicly known to maintain
an unusually close relationship with the senior foreign political figure, and includes a person who is in a position to conduct substantial
domestic and international financial transactions on behalf of the senior foreign political figure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxix)
If the Subscriber is affiliated with a non-U.S. banking institution (a &ldquo;<B><U>Foreign Bank</U></B>&rdquo;), or if the Subscriber
receives deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Subscriber
represents and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a
country in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related
to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank to conduct
banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does not have a physical
presence in any country and that is not a regulated affiliate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxx)
Prior to the Subscriber&rsquo;s entry into this Agreement, Subscriber has had an opportunity to review, and has in fact reviewed, (i)
the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2024; and (ii) the Company&rsquo;s current reports on
Form 8-K and Form 10-Qs as filed with the SEC (which filings can be accessed by going to <U>https://www.sec.gov/edgar/searchedgar/companysearch.html</U>,
typing &ldquo;<B><U>Mangoceuticals</U></B>&rdquo; in the &ldquo;<B><U>Name, ticker symbol, or CIK</U></B>&rdquo; field, and clicking
the &ldquo;<B><U>Submit</U></B>&rdquo; button), from January 1, 2025, to the Effective Date, in each case (i) through (ii), including
the audited and unaudited financial statements, description of business, risk factors, results of operations, certain transactions and
related business disclosures described therein (collectively the &ldquo;<B><U>Disclosure Documents</U></B>&rdquo;) and an independent
investigation made by it of the Company. Subscriber acknowledges that due to its receipt of and review of the information described above,
it has received similar information as would be included in a Registration Statement filed under the Securities Act; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xxxi)
Subscriber acknowledges that he, she or it, is a sophisticated investor capable of assessing and assuming investment risks with respect
to securities, including the Shares, and further acknowledges that the Company is entering into this Agreement with the Subscriber in
reliance on this acknowledgment and with Subscriber&rsquo;s understanding, acknowledgment and agreement that the Company is privy to
material non-public information regarding the Company (collectively, the &ldquo;<B><U>Non-Public Information</U></B>&rdquo;), which Non-Public
Information may be material to a reasonable investor, such as Subscriber, when making investment disposition decisions, including the
decision to enter into this Agreement, and Subscriber&rsquo;s decision to enter into the Agreement is being made with full recognition
and acknowledgment that the Company is privy to the Non-Public Information, irrespective of whether such Non-Public Information has been
provided to Subscriber. Subscriber hereby waives any claim, or potential claim, he has or may have against the Company relating to the
Company&rsquo;s possession of Non-Public Information. Subscriber has specifically requested that the Company not provide it with any
Non-Public Information. Subscriber understands and acknowledges that the Company would not enter into this Agreement in the absence of
the representations and warranties set forth in this paragraph, and that these representations and warranties are a fundamental inducement
to the Company in entering into this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
<U>Indemnification</U>. Subscriber acknowledges that Subscriber understands the meaning and legal consequences of the representations
and warranties in paragraph B hereof, and Subscriber hereby agrees to indemnify and hold harmless the Company and its affiliates, partners,
officers, directors, agents, attorneys, and employees from and against any and all loss, damage or liability due to or arising out of
a breach of any such representations or warranties and the breach of any representations and warranties whatsoever made herein. Notwithstanding
the foregoing, however, no representation, warranty, acknowledgment or agreement made herein by Subscriber shall in any manner be deemed
to constitute a waiver of any rights granted to Subscriber under federal or state securities laws. The representations and warranties
set forth herein shall survive the date upon which the Subscriber becomes a shareholder of the Company and/or the date of this Agreement
in the event the Company does not accept the Subscriber&rsquo;s subscription. No representation, warranty or covenant in this Agreement,
nor the Qualification Questionnaire, contains any untrue statement of a material fact, or omits to state a material fact necessary to
make the statements contained therein, in light of the circumstances under which they were or are to be made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
<U>Compliance with Securities Laws</U>. Subscriber understands and agrees that a legend has been or will be placed on any certificate(s)
or other document(s) evidencing the Securities in substantially the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES ACT. THE
SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS (I) THEY SHALL HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933 AND ANY APPLICABLE STATE SECURITIES ACT, OR (II) THE CORPORATION SHALL HAVE BEEN FURNISHED
WITH AN OPINION OF COUNSEL, SATISFACTORY TO COUNSEL FOR THE CORPORATION, THAT REGISTRATION IS NOT REQUIRED UNDER ANY SUCH ACTS.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
<U>Additional Financings and Offerings</U>. Subscriber recognizes that the Company may seek to raise additional financing and working
capital through a variety of sources in the future, or concurrently with the Offering, and that although the Company may undertake one
or more public or private offerings of its debt or equity securities, there can be no assurance that any such offering will be made or,
if made, that it will be successful. Moreover, Subscriber understands and agrees that the Company reserves the right to make future and
concurrent offers, either public or private, of securities, including, but not limited to, promissory notes, shares of common stock,
preferred stock or warrants, on terms that may be more than or less favorable than the Securities. Subscriber further confirms that Subscriber
has no right to purchase any securities in any future or concurrent offerings. The Company, its affiliates and/or authorized consultants
reserve the right at any time to negotiate individually with one or more prospective investors or other persons and to enter into one
or more definitive agreements and/or side letters, with one or more of such persons regarding an investment in the Company, on the terms
set forth in this subscription or on other terms and conditions, which may be more favorable then the terms set forth herein, or include
additional securities of the Company, without prior notice to Subscriber.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.
<U>Piggyback Registration Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company covenants and agrees that if, at any time prior to the Registration Rights Expiration Date (defined below), it proposes to
file a registration statement with respect to any class of equity or equity-related securities (other than in connection with an offering
to the Company&rsquo;s employees (Form S-8), in connection with an acquisition, merger or similar transaction (Form S-4) or in connection
with the filing of a base Form S-3 registration statement) under the Securities Act in a primary registration on behalf of the Company
and/or in a secondary registration on behalf of holders of such securities, and the registration form to be used may be used for the
issuance or resale of the Shares (the &ldquo;<B><U>Registrable Securities</U></B>&rdquo;), the Company will give prompt written notice
to Purchaser of its intention to file such registration statement and will offer to include in such registration statement, such number
of Registrable Securities with respect to which the Company has received a written request for inclusion therein within three (3) business
days after the giving of notice by the Company (the &ldquo;<B><U>Piggyback Registration Rights</U></B>&rdquo;). Purchaser acknowledges
and understands that the Company shall not be required to include Registrable Securities in a registration statement relating solely
to an offering by the Company of securities for its own account if the managing underwriter or placement agent shall have advised the
Company in writing that the inclusion of such securities will have a material adverse effect upon the ability of the Company to sell
securities for its own account, and provided further that the Purchaser is not treated less favorably than others seeking to have their
securities included in such registration statement. If the registration statement relating to the Piggyback Registration Rights is for
an underwritten offering, such Registrable Securities shall be included in the underwriting on the same terms and conditions as the securities
otherwise being sold through the underwriters. Notwithstanding the obligations set forth above, if any Securities and Exchange Commission
guidance sets forth a limitation on the number of securities permitted to be registered on a particular registration statement as a secondary
offering, the number of Registrable Securities to be registered on such registration statement will be reduced pro rata between the Purchaser
and other parties whose securities are included in such registration statement (including, but not limited to, the other purchasers in
this Offering). The &ldquo;<B><U>Registration Rights Expiration Date</U></B>&rdquo; shall be one year from the date the Company accepts
this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
As a condition to including such Registrable Securities in such registration statement, as applicable, Purchaser shall enter into a confirmation/acknowledgement
agreement with the Company, confirming its beneficial ownership of Company securities, the owners of any entities holding Company securities
which it beneficially owns, the plan of distribution of the registration statement, and such other matters as the Company or its legal
counsel may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Purchaser agrees to sell all Registrable Securities registered under any registration statement and sold in connection therewith,
in compliance with the plan of distribution set forth in such registration statement and any and all applicable prospectus delivery requirements,
and to immediately cease and refrain from selling Registrable Securities, upon written notice from the Company, that any registration
statement registering the resale of the Registrable Securities is not effective, contains any misstatements or omissions, that the prospectus
included in such registration statement no longer complies with the requirements of Section 10 of the Securities Act, or that the prospectus
or registration statement can no longer be relied upon for any reason, until such time as Purchaser is notified by the Company that such
registration statement is effective or such prospectus is compliant with Section 10 of the Securities Act, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Purchaser shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each
person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the
directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against
any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses
(collectively, &ldquo;<B><U>Losses</U></B>&rdquo;), as incurred, to the extent arising out of or based solely upon: (x) such Purchaser&rsquo;s
failure to comply with any applicable prospectus delivery requirements of the Securities Act through no fault of the Company or (y) any
untrue or alleged untrue statement of a material fact contained in any registration statement, any prospectus, or in any amendment or
supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto,
in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue
statement or omission is contained in any information so furnished in writing by such Purchaser to the Company expressly for inclusion
in such registration statement or such prospectus or (ii) to the extent, but only to the extent, that such information relates to such
Purchaser&rsquo;s proposed method of distribution of registrable securities and was reviewed and expressly approved in writing by such
Purchaser expressly for use in a registration statement, such prospectus or in any amendment or supplement thereto or (iii) in the case
such Purchaser uses an outdated, defective or otherwise unavailable prospectus after the Company has notified such Purchaser in writing
that the prospectus is outdated, defective or otherwise unavailable for use by such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.
<U>Confidentiality</U>. Subscriber agrees to maintain in confidence all information furnished by the Company or its agents that may be
deemed to be material nonpublic information, including, but not limited to the fact that the Offering is being made and the terms and
conditions of this Offering and the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.
<U>Governing Law</U>. This Agreement, and all claims or causes of action (whether in contract, tort or statute) that may be based upon,
arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement (including any claim or cause
of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as
an inducement to enter into this Agreement), shall be governed by, and enforced in accordance with, the internal laws of the State of
Texas, including its statutes of limitations, without regard to any borrowing statute that would result in the application of the statute
of limitations of any other jurisdiction. Any actions and proceedings arising out of or relating directly or indirectly to this Agreement
or any ancillary agreement or any other related obligations shall be litigated solely and exclusively in the state or federal courts
located in Dallas County, Texas, and those such courts are convenient forums. Each Party hereby submits to the personal jurisdiction
of such courts for purposes of any such actions or proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.
<U>U.S.A. Patriot Act and Anti-Money Laundering Representations</U>. Subscriber is in full compliance with all applicable U.S. laws,
regulations, directives, and executive orders imposing economic sanctions, embargoes, export controls or anti-money laundering requirements,
including but not limited to the following laws: (1) the International Emergency Economic Powers Act, 50 U.S.C. 1701-1706; (2) the National
Emergencies Act, 50 U.S.C. 1601-1651; (3) section 5 of the United Nations Participation Act of 1945, 22 U.S.C. 287c; (4) Section 321
of the Antiterrorism Act, 18 U.S.C. 2332d; (5) the Export Administration Act of 1979, as amended, 50 U.S.C. app. 2401-2420; (6) the Trading
with the Enemy Act, 50 U.S.C. app. 1 et seq.; (7) the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept
and Obstruct Terrorism Act of 2001, Public Law 107-56; and (8) Executive Order 13224 (Blocking Property and Prohibiting Transactions
with Persons Who Commit, Threaten to Commit, or Support Terrorism) of September 23, 2001. Subscriber will provide additional information
or take such actions as may be necessary or advisable for the Company, in its sole judgment, to comply with any such Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.
<U>Entire Agreement</U>. This Subscription is the entire and fully integrated agreement of the parties regarding the subject matter hereof,
and there are no oral representations, warranties, agreements, or promises pertaining to this Subscription or the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.
<U>Construction</U>. The parties acknowledge that each of them has had the benefit of legal counsel of its own choice and has been afforded
an opportunity to review this Agreement with its legal counsel and that this Agreement shall be construed as if jointly drafted by the
parties hereto. All references in this Agreement as to gender shall be interpreted in the applicable gender of the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.
<U>Purchase Payment</U>. The purchase price for the Securities shall be paid to the Company in cash, check or via wire transfer simultaneously
with the Subscriber&rsquo;s entry into this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.
<U>Construction of Terms</U>. As used in this Agreement, the terms &ldquo;<B><U>herein,</U></B>&rdquo; &ldquo;<B><U>herewith,</U></B>&rdquo;
&ldquo;<B><U>hereof</U></B>&rdquo; and &ldquo;<B><U>hereunder</U></B>&rdquo; are references to this Agreement, taken as a whole; the
term &ldquo;<B><U>includes</U></B>&rdquo; or &ldquo;<B><U>including</U></B>&rdquo; shall mean &ldquo;<B><U>including, without limitation;</U></B>&rdquo;
the word &ldquo;<B><U>or</U></B>&rdquo; is not exclusive; and references to a &ldquo;<B><U>Section,</U></B>&rdquo; &ldquo;<B><U>subsection,</U></B>&rdquo;
&ldquo;<B><U>clause,</U></B>&rdquo; &ldquo;<B><U>Exhibit,</U></B>&rdquo; &ldquo;<B><U>Appendix,</U></B>&rdquo; &ldquo;<B><U>Schedule,</U></B>&rdquo;
&ldquo;<B><U>Annex</U></B>&rdquo; or &ldquo;<B><U>Attachment</U></B>&rdquo; shall mean a Section, subsection, clause, Exhibit, Appendix,
Schedule, Annex or Attachment of this Agreement, as the case may be, unless in any such case the context requires otherwise. Exhibits,
Appendices, Schedules, Annexes or Attachments to any document shall be deemed incorporated by reference in such document. All references
to or definitions of any agreement, instrument or other document (a) shall include all documents, instruments or agreements issued or
executed in replacement thereof, and (b) except as otherwise expressly provided, shall mean such agreement, instrument or document, or
replacement or predecessor thereto, as modified, amended, supplemented and restated through the date as of which such reference is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">O.
<U>Effect of Facsimile and Photocopied Signatures</U>. This Agreement may be executed in several counterparts, each of which is an original.
It shall not be necessary in making proof of this Agreement or any counterpart hereof to produce or account for any of the other counterparts.
A copy of this Agreement signed by one party and (a) faxed to another party or (b) scanned and emailed to another party, shall be deemed
to have been executed and delivered by the signing party as though an original. A photocopy or PDF of this Agreement shall be effective
as an original for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.
<U>Severability</U>. The holding of any provision of this Subscription Agreement to be invalid or unenforceable by a court of competent
jurisdiction shall not affect any other provision of this Subscription Agreement, which shall remain in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Q.
<U>Further Assurances</U>. The parties agree to execute and deliver all such further documents, agreements and instruments and take such
other and further action as may be necessary or appropriate to carry out the purposes and intent of this Subscription Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R.
<U>Collection of Personal Information</U>. The Subscriber acknowledges and consents to the fact the Company is collecting the Subscriber&rsquo;s
(and any beneficial purchaser&rsquo;s) personal information pursuant to this Agreement. The Subscriber (on its own behalf and, if applicable,
on behalf of any person for whose benefit the Subscriber is subscribing) acknowledges and consents to the Company retaining the personal
information for as long as permitted or required by applicable law or business practices. The Subscriber (on its own behalf and, if applicable,
on behalf of any person for whose benefit the Subscriber is subscribing) further acknowledges and consents to the fact the Company may
be required by applicable securities laws and stock exchange rules to provide regulatory authorities any personal information provided
by the Subscriber respecting itself (and any beneficial purchaser). By executing this Agreement, the Subscriber is deemed to be consenting
to the foregoing collection, use and disclosure of the Subscriber&rsquo;s (and any beneficial purchaser&rsquo;s) personal information.
The Subscriber also consents to the filing of copies or originals of any of the Subscriber&rsquo;s documents described herein as may
be required to be filed with any stock exchange or securities regulatory authority in connection with the transactions contemplated hereby.
The Subscriber represents and warrants that it has the authority to provide the consents and acknowledgments set out in this paragraph
on behalf of all beneficial purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;<U>PURCHASER</U>&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
enclosed in the amount of $____________ or Wire Transfer Sent in the Amount of $________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscribed
for __________________ shares of Common Stock at $0.32 per share of Common Stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social
Security or Taxpayer I.D. Number: ________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Address (including zip code): ________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Phone: <U>(&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; )</U>______________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Residence
Address (including zip code) _________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Residence
Phone: <U>(&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; )</U></FONT>_____________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
communications to be sent to: ___________ Business or __________ Residence Address</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt">___________ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
or ____________ Residence Address is the Subscriber&rsquo;s principal residence or place of business (please check as
appropriate).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
Securities should be registered in: _____________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
different than subscriber name please advise of the reason for such difference:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for registration of Securities: _______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address: ________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
indicate on the following pages the form in which you will hold title to your interest in the securities. PLEASE CONSIDER CAREFULLY.
ONCE YOUR SUBSCRIPTION IS ACCEPTED, A CHANGE IN THE FORM OF TITLE CONSTITUTES A TRANSFER OF THE INTEREST IN THE SECURITIES AND MAY THEREFORE
BE RESTRICTED BY THE TERMS OF THIS SUBSCRIPTION, THE SECURITIES AND MAY RESULT IN ADDITIONAL COSTS TO YOU. Subscribers should seek the
advice of their attorneys in deciding in which of the forms they should take ownership of the interest in the securities, because different
forms of ownership can have varying gift tax, estate tax, income tax, and other consequences, depending on the state of the investor&rsquo;s
domicile and his or her particular personal circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
select one of the following forms of ownership:</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDIVIDUAL OWNERSHIP (one
    signature required)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JOINT TENANTS WITH RIGHT
    OF SURVIVORSHIP AND NOT AS TENANTS IN COMMON (both or all parties must sign)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMUNITY PROPERTY (one
    signature required if interest held in one name, i.e., managing spouse; two signatures required if interest held in both names)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TENANTS IN COMMON (both
    or all parties must sign)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL PARTNERSHIP (fill
    out all documents in the name of the PARTNERSHIP, by a PARTNER authorized to sign, and include a copy of the Partnership Agreement)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.8in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIMITED PARTNERSHIP (fill
    out all documents in the name of the LIMITED PARTNERSHIP, by a GENERAL PARTNER authorized to sign, and include a copy of the Limited
    Partnership Agreement and any other document showing that the investment is authorized)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIMITED LIABILITY COMPANY
    (fill out all documents in the name of the LIMITED LIABILITY COMPANY, by a member authorized to sign, and include a copy of the LIMITED
    LIABILITY COMPANY&rsquo;s Operating Agreement and any other documents necessary to show the investment is authorized.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATION (fill out all
    documents in the name of the CORPORATION, by the President or other officer authorized to sign, and include a copy of the Corporation&rsquo;s
    Articles and certified Corporate Resolution authorizing the signature)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRUST (fill out all documents
    in the name of the TRUST, by the Trustee, and include a copy of the instrument creating the trust and any other documents necessary
    to show the investment by the Trustee is authorized. The date of the trust must appear on the Notarial where indicated.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.8in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
ALSO COMPLETE PAGES 16 THROUGH 18, AS APPLICABLE, BELOW, AND THE QUESTIONNAIRE BEGINNING ON PAGE 19 OF THIS SUBSCRIPTION AGREEMENT, WHICH
IS A REQUIRED PART OF THIS AGREEMENT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
execute this Subscription Agreement by completing the appropriate section below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
If the subscriber is an <B>INDIVIDUAL</B>, complete the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
of Subscriber</FONT></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
(please type or print)</FONT></TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
of Spouse or Co-Owner if funds are </FONT>to be invested as joint tenants by the entirety or community property.</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
(please type or print)</FONT></TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
If the subscriber is a <B>CORPORATION</B>, complete the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber hereby represents, warrants and covenants that the Subscriber has been duly authorized by all requisite action on the part
of the corporation listed below (&ldquo;<B><U>Corporation</U></B>&rdquo;) to acquire the Securities and, further, that the Corporation
has all requisite authority to acquire such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
officer signing below represents and warrants that each of the above representations or agreements or understandings set forth herein
applies to that Corporation and that he has authority under the articles of incorporation, bylaws, and resolutions of the board of directors
of such Corporation to execute this Subscription Agreement. Such officer encloses a true copy of the articles of incorporation, the bylaws
and, as necessary, the resolutions of the board of directors authorizing a purchase of the investment herein, in each case as amended
to date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Corporation (please type or print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
If the subscriber is a <B>PARTNERSHIP</B>, complete the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber hereby represents, warrants and covenants that the Subscriber is a general partner of the partnership named below (&ldquo;<B><U>Partnership</U></B>&rdquo;),
and has been duly authorized by the Partnership to acquire the Securities and that he has all requisite authority to acquire such Securities
for the Partnership.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber represents and warrants that each of the above representations or agreements or understandings set forth herein applies to
that Partnership and he is authorized by such Partnership to execute this Subscription Agreement. Such partner encloses a true copy of
the partnership agreement of said Partnership, as amended to date, together with a current and complete list of all partners thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Partnership (please type or print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
If the subscriber is a <B>TRUST</B>, complete the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber hereby represents, warrants and covenants that he is duly authorized by the terms of the trust instrument (&ldquo;<B><U>Trust
Instrument</U></B>&rdquo;) for the (&ldquo;<B><U>Trust</U></B>&rdquo;) set forth below to acquire the Securities and the Subscriber,
as trustee, has all requisite authority to acquire such Securities for the Trust.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber, as trustee, executing this Subscription Agreement on behalf of the Trust, represents and warrants that each of the above
representations or agreements or understandings set forth herein applies to that Trust and he is authorized by such Trust to execute
this Subscription Agreement. Such trustee encloses a true copy of the Trust Instrument of said Trust as amended to date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Trust (Please type or print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
If the subscriber is a <B>LIMITED LIABILITY COMPANY</B>, complete the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subscriber hereby represents, warrants and covenants that the Subscriber has been duly authorized by all requisite action on the part
of the Limited Liability Company listed below (&ldquo;<B><U>Company</U></B>&rdquo;) to acquire the Securities and, further, that the
Company has all requisite authority to acquire such Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
officer signing below represents and warrants that each of the above representations or agreements or understandings set forth herein
applies to that Company and that he has authority under the articles of organization, company agreement, and resolutions of the managers
and/or members, as applicable, of such Company to execute this Subscription Agreement. Such officer encloses a true copy of the articles
of organization, the operating agreement and, as necessary, the resolutions of the managers and/or members authorizing a purchase of
the investment herein, in each case as amended to date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Company (please type or print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 51%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCEPTED
BY THE COMPANY this the ______ day of _________________, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mangoceuticals,
    Inc.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
ALSO COMPLETE THE QUESTIONNAIRE BEGINNING ON PAGE 19 OF THIS SUBSCRIPTION AGREEMENT, WHICH IS A REQUIRED PART OF THIS AGREEMENT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MANGOCEUTICALS,
INC. (THE &ldquo;<U>COMPANY</U>&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVESTOR
APPLICATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(QUALIFICATION
QUESTIONNAIRE)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(CONFIDENTIAL)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALL
INFORMATION CONTAINED IN THIS APPLICATION WILL BE TREATED CONFIDENTIALLY. The undersigned understands, however, that the Company may
present this application to such parties as the Company, in its discretion, deems appropriate when called upon to establish that the
proposed offer and sale of the Securities are exempt from registration of the Securities Act of 1933, as amended, or meet the requirements
of applicable securities and blue sky laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
I </B>- <B>INDIVIDUALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>(including
EACH Co-Tenant, Co-Trustee, Tenant-In-Common, Joint Owner, and person listed in Part II, Section 2).</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Trusts,
LLCs, and Corporations also complete Part II</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
Name: ____________________________________________________________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Residence Address: </B>__________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Residence
Telephone: ___________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
Social Security Number: ______________________________________________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Birth: _____________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Citizenship:
______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
Present Employer: ___________________________________________________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Address: _____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
Telephone: ____________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title/Position:
_________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Length
of Time: ________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
I prefer to have communications sent to:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Home
Address or _________Business Address</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
<U>Investment Experience</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I
have made investments, or been involved in activities, of the type indicated below </B>(recognizing that the types of investments listed
are not mutually exclusive and certain investments may fall into two or more of the categories listed):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHECK
ALL THAT APPLY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership of stocks, bonds,
    and other securities</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in partnerships,
    joint ventures and other syndicates</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other direct or partnership
    investments (such as real estate, oil and gas, equipment leasing, research and development, agriculture or commodities syndications)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Do
you make your own ultimate decisions on your investments?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 36.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YES &#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NO &#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
<U>Method of Investment Evaluation</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
subscriber must have sufficient knowledge and experience in financial and business matters to be capable of evaluating the merits and
risks of an investment in the Company or must retain the services of a Purchaser Representative(s) (who may be an attorney, accountant
or other financial advisor but not a person employed by or associated with the Company or its affiliates) for the purpose of this particular
transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
item is presented in alternative form. Please check the appropriate alternative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AlternativeOne: No Advisor. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have such knowledge and experience in financial and business matters that I am capable of evaluating the merits and risks of an investment
in the Company and of making an informed investment decision, and will not require a Purchaser Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternative Two: Purchaser
    Representative.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have relied upon the advice of the following Purchaser Representative (who is not affiliated with the Company or its affiliates) in evaluating
the merits and risks of an investment in the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(name
of purchaser representative)</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relationship:
<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above-named Purchaser Representative and I together have such knowledge and experience in financial and business matters that we are
capable of evaluating the merits and risks of an investment in the Company and of making an informed investment decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
<U>Accredited Individual Investor</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an individual, I ________________________________________ (PRINT NAME) represent that I (please check all that are applicable):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">have a net worth (either
    individually or jointly with spouse or spousal equivalent) in excess of $1,000,000 in United States Dollars (&ldquo;<B><U>USD</U></B>&rdquo;)
    (not including my principal residence); or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">am an individual who had
    an individual income (NOT including joint income with spouse) in excess of USD $200,000 in each of the two most recent tax years
    and reasonably expects individual income in excess of $200,000 during the current tax year; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">am an individual who had
    an income (including joint income with spouse or spousal equivalent) in excess of USD $300,000 in each of the two most recent tax
    years and reasonably expects individual income in excess of USD $300,000 during the current tax year.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Income</U></B>&rdquo;
for this purpose is computed by adding the following items to adjusted gross income for federal income tax purposes: (a) the amount of
any tax-exempt interest income received; (b) the amount of losses claimed as a limited partner in a limited partnership; (c) any deduction
claimed for depletion; (d) deductions for alimony paid; (e) deductible amounts contributed to an IRA or Keogh retirement plan; and (f)
any amount by which income from long-term capital gains has been reduced in arriving at adjusted gross income pursuant to the provisions
of Section 1202 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 36.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
the undersigned, represent that I do not have any state or federal judicial judgments adverse to me nor are there any state or federal
tax liens against me, nor is there any pending or threatened litigation adverse to me. I, the undersigned, undertake to notify the Company
immediately of any material change in any of such information occurring prior to the closing of the Offering or, if relevant, any time
during the existence of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:&nbsp; </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:&nbsp; </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 43%; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[If
individual purchasers are co-tenants, tenants-in-common or joint owners (including joint owners with such purchaser&rsquo;s spouse) all
co-tenants, tenants-in-common and/or joint owners shall complete a copy of Part I above]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II-INVESTORS WHO ARE <U>NOT</U> INDIVIDUALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
<U>General Information</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity
Name (&ldquo;<B><U>Entity</U></B>&rdquo;)<B>: <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></B></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
of Principal Office: <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
of Organization: <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
and Place of Organization: <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<U>Please
attach a copy of your organizational documents in effect, including any amendments</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
<U>Business</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
brief description of the business conducted by the entity is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
person involved in making the decision on behalf of the entity, to subscribe to purchase Securities is listed below <B>[NOTE AT LEAST
ONE NAME MUST BE LISTED]</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title&nbsp; </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">__________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Please
list any additional names on a separate page].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Each
person named above <U>must</U> complete Part I of this questionnaire.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
<U>Accredited Investor Status of Entity</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
check the appropriate description which applies to you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A bank, as defined in Section
    3 (a)(2) of the Securities Act of 1933, or any savings and loan association or other institution as defined in Section <I>3(a)(5)(A)
    </I>of the Securities Act of 1933, whether you are acting in an individual or a fiduciary capacity.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An insur(a)ance company,
    as defined in Section 2(13) of the&#9;Securities Act of 1933.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An investment company registered
    under the Investment Company Act of 1940.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A business development
    company, as defined in Section (a)(48) of the Investment Company Act of 1940.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A small business investment
    company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An employee benefit plan
    within the meaning of Title I of the Employee Retirement Income Security Act of 1974 and the investment is made by you as a plan
    fiduciary, as defined in Section 3(21) of such Act, and you are a bank, insurance company or a registered investment advisor, or
    you have total assets in excess of $5 million.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A private business development
    company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An organization described
    in Section 501 (c)(3) of the Internal Revenue Code, a corporation, a Massachusetts or similar business trust, or a partnership, not
    formed for the specific purpose of acquiring Securities, with total assets in excess of $5 million.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An entity <B>(other than
    a trust, which <U>must</U> meet the requirements set forth in Section (j), below)</B> in which all of the equity owners are accredited
    investors and meet at least one of the criteria listed in Part I, Section 8 of this Questionnaire.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_____</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A trust with total assets
    in excess of $5,000,000 not formed for the specific purpose of acquiring Securities, whose purchase is directed by a person with
    such knowledge and experience in financial and business matters that (s)he is capable of evaluating the merits and risks of the prospective
    investment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you checked (i), please complete the following part of this question:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List all equity owners:
    __________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">What is the type of entity?
    _______________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attach a copy of your resolutions
    or other evidence of the entity&rsquo;s authority to make this investment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represent that each equity
    owner qualifies individually to Part I, Section 9 of this Questionnaire by printing each equity owners name below (you may include
    an additional sheet if necessary):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please confirm that the entity was not formed solely
    for the purpose of subscribing for Securities in the Offering by initialing below:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
<U>Representations</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned represents on behalf of the entity that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 38.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The entity has, and its officers, employees, directors or equity owners have, sufficient knowledge and experience in similar programs
or investments to evaluate the merits and risks of an investment in the Company (or the entity has retained an attorney, accountant,
financial advisor or consultant as a Purchaser Representative); that because of the background and employment experience of the entity&rsquo;s
equity owners, its officers, directors or employees, it has received and has had access to material and relevant information enabling
it to make an informed investment decision, and that all data it has requested has been furnished to it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>If
applicable, the name, employer, address and telephone number of the entity&rsquo;s Purchaser Representative follows:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The information contained herein is complete and accurate and may be relied upon by you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attached
is the requested information (e.g., articles of incorporation, bylaws and resolutions) for your review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned represents that the information provided above is true and correct and acknowledges such investor&rsquo;s awareness that
the Company, and other investors are relying upon the accuracy of such information to ensure that the sale of any securities by the Company
to such investor is in compliance with applicable federal and state securities laws. The undersigned represents that neither the entity
it represents nor, its officers, directors or shareholders have any state or federal judicial judgments adverse to them nor are there
any state or federal tax liens against them, nor is there any pending or threatened litigation adverse to them. The undersigned undertakes
to notify the Company immediately of any material change in any of such information occurring prior to the closing of the Offering, or,
if relevant, any time during the existence of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Entity</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Entity Typed or Printed: <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
ALSO CONFIRM THAT EACH PERSON NAMED IN PART II, SECTION 2, ABOVE HAS COMPLETED PART I OF THIS QUESTIONNAIRE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
FOR RESIDENTS OF CERTAIN STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
prospective purchaser should read the legend and/or state disclosure listed below applicable to the state in which he resides. The state
disclosures and/or legends listed below do not in any way constitute or imply that offers or sales may be made in such states. Offers
and/or sales may only be made in those states approved by the Company. If any prospective purchaser resides in a state not included below,
such prospective investor should request the state legend applicable to such purchaser&rsquo;s state prior to making an investment in
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>California
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sale of the securities which are the subject of this offering has not been qualified with Commissioner of Corporations of the State of
California and the issuance of such securities or payment or receipt of any part of the consideration therefore prior to such qualifications
is unlawful, unless the sale of securities is exempted from qualification by the California Corporations Code. The rights of all parties
to this offering are expressly condition upon such qualifications being obtained, unless the sale is so exempt. Accordingly, distribution
of this document and offers and sales of the securities referred to herein are strictly limited to persons who the Company determines
to have met certain financial and other requirements. This document does not constitute an offer to sell or the solicitation of an offer
to buy with respect to any other person. In order to rely on the foregoing exemptions, the Company will rely in turn on certain representations
and warranties made to the Company by the investors in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Connecticut
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities offered herein have not been registered under section 36-485 of the Connecticut Uniform Securities Act (the &ldquo;<B><U>Act</U></B>&rdquo;)
and, therefore, cannot be resold unless they are registered under the Act or unless an exemption from registration is available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Florida
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities have not been registered under the Florida Securities and Investor Protection Act in reliance upon exemption provisions contained
therein. Section 517.061(11)(a)(5) of the Florida Securities and Investor Protection Act (the &ldquo;<B><U>Florida Act</U></B>&rdquo;)
provides when sales are made to five or more purchasers in this state that any purchaser of securities in Florida which are exempted
from registration under Section 517.061(11) of the Florida Act may withdraw his subscription agreement and receive a full refund of all
monies paid, within three days after the later of (i) the date he tenders consideration for such securities and (ii) the date this statutory
right of rescission is communicated to him (which shall be established conclusively by the Company&rsquo;s provision of this &ldquo;<B><U>Information
for Residents of Certain States</U></B>&rdquo;). Any Florida resident who purchases securities is entitled to exercise the foregoing
statutory rescission right by telephone, telegram, or letter notice to the Company. Any telegram or letter should be sent or postmarked
prior to the end of the third business day. A letter should be mailed by certified mail, return receipt requested, to ensure its receipt
and to evidence the time of mailing. Any oral requests should be confirmed in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
AVAILABILITY OF THE PRIVILEGE TO VOID SALES PURSUANT TO SECTION 517.061 OF THE FLORIDA ACT IS HEREBY COMMUNICATED TO EACH FLORIDA INVESTOR.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Georgia
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities sold in the state of Georgia have been issued or sold in reliance on paragraph (I3) of Code section 10-5-9 of the Georgia
Securities Act of 1973, and may not be sold or transferred except in a transaction which is exempt under such Act or pursuant to an effective
registration under such Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Illinois
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities have not been approved or disapproved by the Secretary of State of Illinois, nor has the Secretary of State of Illinois nor
the State of Illinois passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Indiana
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities have not been registered under Section 3 of the Indiana Securities Act and therefore, cannot be resold or transferred unless
they are so registered or unless an exemption from registration is available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Maryland
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities which are the subject of this subscription agreement have not been registered under the Maryland Securities Act in reliance
upon the exemption in section 11-602(9) of such act. Unless these Securities are registered, they may not be re-offered for sale or resold
in the State of Maryland, except as security, or in a transaction exempt under such Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Michigan
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities have not been registered under Section 451.701 of the Michigan Uniform Securities Act (the Act) and may be transferred or
resold by residents of Michigan only if registered pursuant to the provisions of the Act, or if an exemption from registration is available.
The investment is suitable if it does not exceed 10% of the investor&rsquo;s net worth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Minnesota
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities represented by this subscription agreement have not been registered under Chapter 80A of the Minnesota Securities Laws and
may not be sold, transferred or otherwise disposed of except pursuant to registration or an exemption therefrom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Nevada
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities have not been approved or disapproved by the Secretary of State of Nevada, nor has the Secretary of State of Nevada nor the
State of Nevada passed upon the accuracy or adequacy of the information set forth herein. Any representation to the contrary is a criminal
offense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>New
Jersey Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities have not been approved or disapproved by the Bureau of Securities of the State of New Jersey, nor has the Bureau passed on
or endorsed the merits of this Offering. The filing of the written Offering does not constitute approval of the issue or the sale thereof
by the Bureau of Securities. Any representation to the contrary is unlawful.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
are speculative securities and involve a high degree of risk. These securities are offered only to bona fide adult residents of the State
of New Jersey.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>New
York Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document has not been reviewed by the Attorney General of the State of New York prior to its issuance and use. The Attorney General of
the State of New York has not passed on or endorsed the merits of this offering. Any representation to the contrary is unlawful. The
Company has taken no steps to create an after market for the securities offered herein and has made no arrangements with brokers of others
to trade or make a market in the securities. At some time in the future, the Company may attempt to arrange for interested brokers to
trade or make a market in the securities and to quote the same in a published quotation medium, however, no such arrangements have been
made and there is no assurance that any brokers will ever have such an interest in the securities of the Company or that there will ever
be a market therefore.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Oklahoma
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered herein have not been registered under the Oklahoma Securities Act (the &ldquo;<B><U>Oklahoma Act</U></B>&rdquo;),
and therefore Cannot be resold or transferred by the investor in a transaction Which is exempt under the Oklahoma Act or pursuant to
an effective Registration under the Oklahoma Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Ohio
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities have not been approved or disapproved as an investment for any Ohio resident by the Ohio Division of Securities nor has the
Division passed upon the accuracy of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Pennsylvania
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Residents
of the Commonwealth of Pennsylvania can only transfer the Securities offered hereby in accordance with the provisions of section 203(d)
of the Pennsylvania Securities Act of 1972 and are subject to the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
Under the provisions of the Pennsylvania Securities Act of 1972, a Pennsylvania resident who accepts an offer to purchase securities
exempted from registration by section 203(d)(f)(p) or (r) directly from an issuer or affiliate of an issuer shall have the right to withdraw
his acceptance without incurring any liability to the seller, underwriter, if any, or any other person, within two business days from
the date of receipt by the issuer of this written binding contract to purchase, or in the case of a transaction where there is no written
binding contract to purchase, within two business days after he makes the initial payment for the securities being offered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Pursuant to Section 203.041(c)(1) of the Pennsylvania Blue Sky Regulations (&ldquo;<B><U>Regulations</U></B>&rdquo;)<B>, </B>the purchaser
must acknowledge that he or she agrees not to sell the securities purchased herein within 12 months after the date of purchase except
in accordance with Section 204.011 of the Regulations. Section 204.011 provides for an automatic waiver of the 12 month holding period
under certain conditions including that the securities purchased are subsequently being registered under the Securities Act of 1933 or
1934.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Texas
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered hereunder have not been registered under applicable Texas securities laws and, therefore, any purchaser thereof must
bear the economic risk of the investment for an indefinite period of time because the securities cannot be resold unless they are subsequently
registered under such securities laws or an exemption from such registration is available. Further, pursuant to &sect;109.13 under the
Texas Securities Act, the Company is required to apprise prospective investors of the following: a legend shall be placed, upon issuance,
on certificates representing securities purchased hereunder, and any purchaser hereunder shall be required to sign a written agreement
that he will not sell the subject securities without registration under applicable securities laws or exemptions therefrom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Wisconsin
Residents</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Securities Commission of the State of Wisconsin has not passed upon the merits or qualifications of, or recommended or given approval
to, the securities hereby offered, nor has the Securities Commissioner of this state passed upon the adequacy of this subscription agreement.
Any representation to the contrary is a criminal offense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
investor must rely on his own examination of the person or entity creating the securities and the terms of the Offering, including the
merits and risks involved in making an investment decision on these securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>NASAA
UNIFORM LEGEND</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
making an investment decision investors must rely on their examination of the offering, including the merits and risks involved. These
securities have not been recommended by a federal or state securities commission or regulatory authority. Furthermore, the foregoing
authorities have not confirmed the accuracy or determined the adequacy of this document. Any representation to the contrary is a criminal
offense. These securities are subject to restrictions on transferability and resale and may not be transferred or resold except as permitted
under the Securities Act of 1933, as amended, and the applicable state securities laws, pursuant to registration or exemption therefrom.
Investors should be aware that they will be required to bear the investment risks of this investment for an indefinite period of time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 27; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> of 27</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Subscription Agreement</TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center">Mangoceuticals, Inc.</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mgrx-20260629.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWayO6bP9z5Z8aekhvWBzbUkaXykhFk1vHiPOJLh2QcsD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:srt-types="http://fasb.org/srt-types/2026" xmlns:MGRX="http://mangoceuticals.com/20260629" elementFormDefault="qualified" targetNamespace="http://mangoceuticals.com/20260629">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://mangoceuticals.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="mgrx-20260629_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="mgrx-20260629_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" />
    <import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" />
    <import namespace="http://fasb.org/us-types/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2026" schemaLocation="https://xbrl.sec.gov/country/2026/country-2026.xsd" />
    <import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd" />
    <import namespace="http://fasb.org/srt-types/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mgrx-20260629_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mgrx-20260629_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="mgrx-20260629.xsd#Cover" roleURI="http://mangoceuticals.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://mangoceuticals.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 29, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 29,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MANGOCEUTICALS,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001938046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-3841292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">17130
    N. Dallas Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">242-9619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 Par
    Value Per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MGRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mangoceuticals.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>mgrx-20260629.xsd</File>
    <File>mgrx-20260629_lab.xml</File>
    <File>mgrx-20260629_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "MGRX",
   "nsuri": "http://mangoceuticals.com/20260629",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "mgrx-20260629.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mgrx-20260629_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mgrx-20260629_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 24
   },
   "report": {
    "R1": {
     "role": "http://mangoceuticals.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-06-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-06-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CountryRegion",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Extension",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12gTitle",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://mangoceuticals.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001493152-26-031917-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-26-031917-xbrl.zip
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ML]VR5ZVU5F'AQG(BXQB&$L9Z*F,)TP(OJSS?W%/?U=I9-WO$NAXVTL@:4&A
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M2(#4ATWE!E&"6YY:[T #8%>Y4EK-<:X=/W#&T%F\UY_-I.?C.9C!J,#9;1T
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MDI_\A.UPBL2%X@KQF1@Y(X<ZVV[X>$J_43I(PD&P"9N/5E_WRO%'.#I#1TS
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M.;17$+)772P5*)=6>2")PS(EUY()IZ-[( O5B96PES69,CX:VQ7*FV3NS/&
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MB\YCV72(( JOR)Y>,2G;ME>V=H/3#M=9'TFZ(I)M\>R%F'8135X)V"7E0*G
M(\NJ2>^R@RU0J:#ZSSJGY>MV:^=P5U&B5.I9J>,U6#R9@GIERJA9KYHZUUP
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M9_^EN?7P\,"#>U_L*N\\C7[7*LUCO_;'G^S*RG:W8(W PYY#WPZ>'SR#!_[
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M#.>/W0XS..UB"@I^I3(?@L#00L%#H!&J$A?#?756BY;EG-K"<&1ZO9,*S+4
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MC@.6;9&4%5>R3#!UMFSD8&MV?/MV,Z(93.RBW2*C 5\"YX'+QI9*QYYE(5H
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M'L4*QE,QR%?"[.6-:"\/IJ\\E)S Y^V,B-9HAC'*F!PY>G)[]X+YO%K@W+,
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MGS0V$K6S<GJFB2VEI4&_K54'T"0); L$#GO4!H0ZQ.DQ#=-M.N'09<(A@.^
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M<0I[Y=W^1JCBYNACK\1A A$$G ,86"\>E6-,FV?PR]IH+I,8MQJ_[T0-M)+
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MX-$'7QTZEU\=LC]:8NO1C$QNEYQ[)T)VR EUQ"I!\UB"YO7R)6^XU!L2NL'
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M()SK]HPNR#O?UP(-*U%3R]]02P,$%     @ SJ/B7-?P#?3]"@  ?X8  !4
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M4+24KKD K)IH&+*@Z+![ P&IY'X960C,TD0-8+V0M*7.3S< LZU3#T,7%">
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M2? "TAJ&O.='-=X#$RA8E,RN4@[2F'"SBN=$S*A_]4*U)10P2J87$H<V]LY
M8^_LA6,O2L;G$X7$ME@;;L^HNPEG,^+?218L -YG@TD\(+7I_7OYEA^WHUNE
MN1]#^Z$:N\<4"AQGBV1(7M.HLX09FA0N#9D@(K8IU79?FR<[KR\%#0#.'DJ@
M:)3'^]\HYQ^%7(HQ)5H*FA2W^J$G_-XBT"@@SB'6R$4)P5?),TM)Y0M!E><<
M\)A"D2/.'7KDX:R]+!8U;Z\]Q:L[0L1]):#@$2<1PV*1UJ<9ZGQFS_0],63C
M88B_KP24/^*$8E@LVOIY-; 7GID,SYD?&$)I(RZ%K92& GF<$L[?99H)JH-C
MRX$A%#+BFM=*:2B0;U*J9G90^Z#DTLPW>SM#L#T%H- 15[8&I>+ 7_W81U[L
M?PN2K[ &OYT $;M7)-9K-^+8+:0HKN0B(<I#/60/Y8ZZL=(OM&'R=V9.U>[]
M4^[,R.9MH44/]:6@44!)5Z&B<:ZM.SOY@Y?6/3LH;\3$M$H8SIZI;,)9/.22
M!._+]\R@?!&ST I9*'C?$?&DLH6)U_=*QI2ZZ1.]/=L "1&P FA($//3%Z'
M>5P@T]1M)I+QTWAN1>N[S.0O,K7^!1\:!,M!0X.YB1,@'.DN2/_8Z$63=^L'
M.J7*+5-XI"OSSC;T%+XI A2'Q@?UC4)@#!5ANNP<Z;JU!]R[:HMOW"_W/E9[
MY']02P$"% ,4    " #.H^)<.HLDRG!S  "&TP, "@              @ $
M    97@Q,"TQ+FAT;5!+ 0(4 Q0    ( ,ZCXER/S(#T:!4  )&B   +
M          "  9AS  !F;W)M."UK+FAT;5!+ 0(4 Q0    ( ,ZCXEPZMVU[
M+ ,  /0+   1              "  2F)  !M9W)X+3(P,C8P-C(Y+GAS9%!+
M 0(4 Q0    ( ,ZCXES7\ WT_0H  '^&   5              "  82,  !M
M9W)X+3(P,C8P-C(Y7VQA8BYX;6Q02P$"% ,4    " #.H^)<EN&L5ET'  #@
M5P  %0              @ &TEP  ;6=R>"TR,#(V,#8R.5]P<F4N>&UL4$L%
3!@     %  4 -@$  $2?      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mgrx-20260629.xsd" xlink:type="simple"/>
    <context id="AsOf2026-06-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001938046</identifier>
        </entity>
        <period>
            <startDate>2026-06-29</startDate>
            <endDate>2026-06-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-06-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-06-29" id="Fact000004">0001938046</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2026-06-29" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-06-29" id="Fact000010">2026-06-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-06-29" id="Fact000011">MANGOCEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-06-29" id="Fact000012">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-06-29" id="Fact000013">001-41615</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-06-29" id="Fact000014">87-3841292</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-06-29" id="Fact000015">17130     N. Dallas Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2026-06-29" id="Fact000016">Suite 240</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-06-29" id="Fact000017">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-06-29" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-06-29" id="Fact000019">75248</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-06-29" id="Fact000020">(214)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-06-29" id="Fact000021">242-9619</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-06-29" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-06-29" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-06-29" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-06-29" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2026-06-29" id="Fact000026">Common Stock, $0.0001 Par     Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-06-29" id="Fact000027">MGRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-06-29" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-06-29" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2026-06-29" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
